Status:
UNKNOWN
Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples.
Lead Sponsor:
Assiut University
Conditions:
New Tumor Diagnostics From Human Plasma Samples
Eligibility:
All Genders
50-90 years
Brief Summary
Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples.
Detailed Description
Cell free circulating free nucleic acids is new substrates for laboratory diagnostics in a number of medical areas including oncology, transfusion medicine, gynecology/obstetrics, inflammatory and aut...
Eligibility Criteria
Inclusion
- patients with Melanoma
Exclusion
- patients with other types of malignancies
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04081194
Start Date
October 1 2016
End Date
December 1 2019
Last Update
September 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospitals- Faculty of Medicine
Asyut, Egypt, 71111